Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in ...
The data indicated that baby boomers experienced the greatest decrease in the number of nones from 2023 to 2024, falling from ...
A White House official says the Trump administration is planning to halt more than half a billion dollars in contracts and ...
On April 1, the Trump administration slashed the Agency for Healthcare Research and Quality, or AHRQ, and fired roughly half ...
Researchers who had millions of dollars' worth of grants terminated by the National Institutes of Health are suing the ...
In another case, a challenge to Trump’s order restricting birthright citizenship, the Court set a briefing schedule so ...
Explore more
The sweeping order gives K-12 state education agencies 10 days to collect the certifications of compliance, sign them and return them to the federal department ...
Here are the top five high schools in Vermont based on the number of students from the class of 2024 who matriculated at a ...
The list, which was released this week by PolarisList, ranks high schools around the nation based on one factor: the number ...
Dr. Jeffrey Flier is an endocrinologist and a professor at Harvard Medical School, where he was the dean from 2007 to 2016.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results